• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX15RWC W/ 3L RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX15RWC W/ 3L RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX15RW30C
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/04/2022
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, it was noticed that there was diluted blood came off from the fiber bundle to the external shell.They were on cardiopulmonary bypass for 162 minutes with no issues.However, when breaking down the circuit dilute blood came off from the fiber bundle to the external shell.The heparin bolus was given by anesthesia at 11:31 and cpb was initiated at 11:58 which equates to a 27-minute difference.Heparin concentration levels and acts were monitored throughout the case.Listed out below the act and [hep] in order as they appear on the patient record.Post heparin act at 11:38 = 489 and [hep] = 1.5 first sample upon initiation of cpb: act = 625, [hep] = 2.0.Act = 585, [hep] = 2.0.Act = 650.Act = 480, [hep] = 2.0.Post protamine act at 15:16 = 116 and [hep] = 0.0.Came off cpb at 14:40 and the circuit sat slowly circulating until around 17:00 as the surgeon was implanting pacemaker leads.Although not on cpb supporting the patient, the circuit sat for several more hours and would have been used close to the 6-hour maximum time allotted.No known impact or consequences to patient.The product was not changed out.The surgery was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on december 6, 2022.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added expiration date) g3 (date received by manufacturer) g6 (indication that this is a follow-up report) h2 (follow-up due to additional information) h4 (device manufacture date) h6 (identification of evaluation codes 3113, 4114, 4210, 4315) type of investigation: #1: 3331 - analysis of production records type of investigation #2: 4114 - device not returned investigation finding: 4210 - leakage/seal investigation conclusions: 4315 - cause not established the affected sample was not returned for evaluation; however, an image that was provided confirmed a red liquid found on the gas inlet.The manufacturing record and incoming inspection record of the actual product found no anomaly in three putative lot numbers.Since the product could be used without problems for 162 minutes after the start of circulation, it was inferred that the leakage was not coming from the fiber bundle but due to plasma leakage.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX15RWC W/ 3L RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
jamie quinlan
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key15927274
MDR Text Key308096403
Report Number1124841-2022-00180
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450783
UDI-Public(01)00699753450783
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151389
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3CX*FX15RW30C
Device Catalogue NumberN/A
Device Lot Number2A31
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/09/2022
Initial Date FDA Received12/06/2022
Supplement Dates Manufacturer Received01/12/2023
Supplement Dates FDA Received01/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age32 YR
Patient SexMale
Patient Weight57 KG
-
-